JP2014509868A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014509868A5 JP2014509868A5 JP2014501270A JP2014501270A JP2014509868A5 JP 2014509868 A5 JP2014509868 A5 JP 2014509868A5 JP 2014501270 A JP2014501270 A JP 2014501270A JP 2014501270 A JP2014501270 A JP 2014501270A JP 2014509868 A5 JP2014509868 A5 JP 2014509868A5
- Authority
- JP
- Japan
- Prior art keywords
- expression
- seq
- level
- kit
- gene product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161467999P | 2011-03-26 | 2011-03-26 | |
| US61/467,999 | 2011-03-26 | ||
| PCT/US2012/030309 WO2012135008A1 (en) | 2011-03-26 | 2012-03-23 | Gene expression predictors of cancer prognosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014509868A JP2014509868A (ja) | 2014-04-24 |
| JP2014509868A5 true JP2014509868A5 (https=) | 2015-05-07 |
Family
ID=46931859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014501270A Pending JP2014509868A (ja) | 2011-03-26 | 2012-03-23 | 癌の予後のための遺伝子発現予測因子 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20140113297A1 (https=) |
| EP (1) | EP2691547A4 (https=) |
| JP (1) | JP2014509868A (https=) |
| CA (1) | CA2831074A1 (https=) |
| WO (1) | WO2012135008A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8338109B2 (en) | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| EP2806054A1 (en) | 2008-05-28 | 2014-11-26 | Genomedx Biosciences Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US20120041274A1 (en) | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
| EP3812469A1 (en) | 2010-07-07 | 2021-04-28 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| US9605319B2 (en) | 2010-08-30 | 2017-03-28 | Myriad Genetics, Inc. | Gene signatures for cancer diagnosis and prognosis |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| EP2791359B1 (en) | 2011-12-13 | 2020-01-15 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| SG11201408434QA (en) * | 2012-06-28 | 2015-01-29 | Caldera Health Ltd | Targeted rna-seq methods and materials for the diagnosis of prostate cancer |
| DK3435084T3 (da) | 2012-08-16 | 2023-05-30 | Mayo Found Medical Education & Res | Prostatakræftprognose under anvendelse af biomarkører |
| WO2014078700A1 (en) | 2012-11-16 | 2014-05-22 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| EP2971177B1 (en) * | 2013-03-14 | 2019-09-11 | Neogenomics Laboratories, Inc. | Compositions and methods for detecting and determining a prognosis for prostate cancer |
| EP2971174A4 (en) * | 2013-03-14 | 2017-06-14 | Genomedx Biosciences Inc. | Cancer biomarkers and classifiers and uses thereof |
| EP3143160B1 (en) | 2014-05-13 | 2019-11-06 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| US11174518B2 (en) | 2015-10-05 | 2021-11-16 | Cedars-Sinai Medical Center | Method of classifying and diagnosing cancer |
| EP3504348B1 (en) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| EP3571322B9 (en) | 2017-01-20 | 2023-10-04 | VERACYTE SD, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| EP3593140A4 (en) | 2017-03-09 | 2021-01-06 | Decipher Biosciences, Inc. | SUBTYPING PROSTATE CANCER TO PREDICT RESPONSE TO HORMONE THERAPY |
| CA3062716A1 (en) | 2017-05-12 | 2018-11-15 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
| US11083127B2 (en) | 2018-05-09 | 2021-08-10 | Deere & Company | Seeding machine to provide transverse tramlines |
| WO2022011425A1 (en) * | 2020-07-15 | 2022-01-20 | Queensland University Of Technology | Determining cancer responsiveness to treatment |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7526387B2 (en) * | 2003-07-10 | 2009-04-28 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
| US20080275652A1 (en) * | 2005-05-13 | 2008-11-06 | Universite Libre De Bruxelles | Gene-based algorithmic cancer prognosis |
| US7914988B1 (en) * | 2006-03-31 | 2011-03-29 | Illumina, Inc. | Gene expression profiles to predict relapse of prostate cancer |
| EP2520935A3 (en) * | 2006-08-09 | 2013-02-13 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
| US8470534B2 (en) * | 2006-12-01 | 2013-06-25 | Erik S. Knudsen | Methods of predicting resistance or sensitivity to therapies for cancer |
| EP2806054A1 (en) * | 2008-05-28 | 2014-11-26 | Genomedx Biosciences Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US20090298082A1 (en) * | 2008-05-30 | 2009-12-03 | Klee George G | Biomarker panels for predicting prostate cancer outcomes |
| EP2315858A2 (en) * | 2008-07-08 | 2011-05-04 | Source Precision Medicine, Inc. | Gene expression profiling for predicting the survivability of prostate cancer subjects |
| KR20110111462A (ko) * | 2009-01-07 | 2011-10-11 | 미리어드 제네틱스, 인크. | 암 바이오마커 |
| WO2010129965A1 (en) * | 2009-05-08 | 2010-11-11 | The Regents Of The University Of California | Cancer specific mitotic network |
| CA3043089A1 (en) * | 2009-11-23 | 2011-05-26 | Genomic Health, Inc. | Methods to predict clinical outcome of cancer |
| EP3812469A1 (en) * | 2010-07-07 | 2021-04-28 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
-
2012
- 2012-03-23 EP EP12765325.1A patent/EP2691547A4/en not_active Withdrawn
- 2012-03-23 WO PCT/US2012/030309 patent/WO2012135008A1/en not_active Ceased
- 2012-03-23 JP JP2014501270A patent/JP2014509868A/ja active Pending
- 2012-03-23 US US14/007,527 patent/US20140113297A1/en not_active Abandoned
- 2012-03-23 CA CA2831074A patent/CA2831074A1/en not_active Abandoned
-
2016
- 2016-02-18 US US15/047,533 patent/US20160168649A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014509868A5 (https=) | ||
| Maltseva et al. | High-throughput identification of reference genes for research and clinical RT-qPCR analysis of breast cancer samples | |
| KR101562644B1 (ko) | 직장결장암용 예후 예측 | |
| ES2525382T3 (es) | Método para la predicción de recurrencia del cáncer de mama bajo tratamiento endocrino | |
| CA2776751C (en) | Methods to predict clinical outcome of cancer | |
| JP6219824B2 (ja) | びまん性大細胞型ｂ細胞性リンパ腫（ｄｌｂｃｌ）患者における抗−ｃｄ２０療法に対する応答の予測 | |
| KR20140105836A (ko) | 다유전자 바이오마커의 확인 | |
| JP2006506945A (ja) | 遺伝子発現プロフィールを使用する非小細胞肺癌の診断および処置のための方法および組成物 | |
| JP2019004907A (ja) | メラノーマ癌の予後予測 | |
| SG192108A1 (en) | Colon cancer gene expression signatures and methods of use | |
| AU2004211955A1 (en) | Gene expression markers for response to EGFR inhibitor drugs | |
| JP2014509868A (ja) | 癌の予後のための遺伝子発現予測因子 | |
| US20160186270A1 (en) | Signature of cycling hypoxia and use thereof for the prognosis of cancer | |
| Wu et al. | Systematic analysis of transcribed loci in ENCODE regions using RACE sequencing reveals extensive transcription in the human genome | |
| Zhang et al. | Comprehensive analysis of prognostic value of MEX3A and its relationship with immune infiltrates in ovarian cancer | |
| WO2015127101A1 (en) | Method and composition for diagnosis of aggressive prostate cancer | |
| US20180046754A1 (en) | Normalization methods for measuring gene copy number and expression | |
| CN108474041A (zh) | 使用遗传标记的甲基化状态区分转移性-致死性前列腺癌与惰性前列腺癌 | |
| Rajawat | Transcriptomics | |
| CN114032308B (zh) | Fam83a、kpna2、krt6a和ldha联合作为肺腺癌生物标志物的用途 | |
| EP3196316B1 (en) | METHOD AND DEVICE FOR COMPARATIVE ANALYSIS OF miRNA EXPRESSION LEVEL | |
| US20230340611A1 (en) | Biomarkers For Immune Checkpoint Inhibitors Treatment | |
| CN110387411A (zh) | 用于检测狼疮性肾炎或评估狼疮性肾炎风险的方法及其应用 | |
| KR20230028619A (ko) | 아토피성 피부염 진단용 바이오마커 및 이의 용도 | |
| WO2013132354A2 (en) | Gene signatures associated with efficacy of postmastectomy radiotherapy in breast cancer |